Julie O'Neill

Julie O'Neill currently works at HOOKIPA Pharma, Inc., as Independent Non-Executive Chairman from 2024, ICON plc, as Independent Non-Executive Director from 2019, ILC Dover LP, as Director from 2021, DBV Technologies SA, as Independent Director from 2017, Advancion Corp., as Director from 2021, American Chamber of Commerce Ireland, as Director, Achilles Therapeutics Plc, as Non-Executive Director from 2021, National Institute for Bioprocessing Research & Training, as Director from 2022, University College Cork, as Member, and Institute of Directors In Ireland, as Principal.
Ms. O'Neill also formerly worked at National Standards Authority of Ireland, as Chairman, Alexion Pharmaceuticals, Inc., as Executive Vice President-Global Operations from 2015 to 2018, Alexion Pharma International Operations Ltd., as Senior VP-Global Manufacturing Operations & GM from 2014 to 2015, and Gilead Sciences Ireland UC, as Vice President-Global Operations & GM-Ireland from 2011 to 2014.
Ms. O'Neill received her Masters Business Admin degree from University College Dublin and undergraduate degree from Trinity College Dublin.